Skip to main content
. 2021 Feb 8;93:107398. doi: 10.1016/j.intimp.2021.107398

Fig. 2.

Fig. 2

Leflunomide inhibits the immune system through inhibition of tyrosine kinase phosphorylation of the JAK3/STAT6 and immunoglobulin class switching.